RecruitingNCT01694940
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Sponsor
Columbia University
Enrollment
1,000 participants
Start Date
Jan 31, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Eligibility
Inclusion Criteria4
- Patients diagnosed with or suspected to have a mitochondrial disorder
- Adult carriers of known mitochondrial DNA mutations
- Patients with laboratory analysis indicative of a mitochondrial disorder.
- Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.
Exclusion Criteria2
- Patients not suspected of having a mitochondrial disorder
- Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01694940
Related Trials
The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
NCT017801681 location
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy
NCT074506901 location
Mitochondrial Substrate Utilization in the Diabetic Human Heart
NCT059587061 location
Mitochondrial Disease-associated ImmunoDeficiencies
NCT062131032 locations
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
NCT0645175710 locations